Fibroblast Growth Factor Receptor-4 Expression in Pituitary Adenomas is Associated with Aggressive Tumor Features

DURCAN E., Keskin F. E., ÖZKAYA H. M., ŞİROLU S., Sahin S., Korkmaz O. P., ...Daha Fazla

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, cilt.130, sa.2, ss.125-133, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 130 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1055/a-1523-7216
  • Dergi Adı: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.125-133
  • Anahtar Kelimeler: FGFR-4, Ki-67, pituitary adenomas, tumor aggressiveness
  • İstanbul Üniversitesi Adresli: Evet

Özet

Purpose To investigate the relationship of Fibroblast Growth Factor Receptor-4 (FGFR-4) expression with radiologic, pathologic, and clinical parameters in pituitary adenomas.